NIKA PHARMACEUTICALS, INC (NIKA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$79.7K | +48.6% |
| 2024 | -$154.9K | -139.0% |
| 2023 | -$64.8K | -292.3% |
| 2022 | $33.7K | +129.2% |
| 2021 | $14.7K | +265.2% |
| 2020 | -$8.9K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$79.7K | +48.6% |
| 2024 | -$154.9K | -139.0% |
| 2023 | -$64.8K | -292.3% |
| 2022 | $33.7K | +129.2% |
| 2021 | $14.7K | +265.2% |
| 2020 | -$8.9K | — |